Flexion Therapeutics, Inc. Total Assets
Flexion Therapeutics, Inc. had Total Assets of $217.93 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2021-11-12
- 2021-09-30: Assets $217.93M.
- 2021-06-30: Assets $210.05M.
- 2021-03-31: Assets $230.38M.
- 2020-12-31: Assets $251.93M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2021-09-30 | $217.93M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $210.05M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $230.38M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $251.93M 10-Q · filed 2021-11-12 | |
| 2020-09-30 | $263.37M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $271.78M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $204.58M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $217.56M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $244.35M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $232.48M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $264.62M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $295.75M 8-K · filed 2020-05-20 | |
| 2018-09-30 | $331.69M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $362.53M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $397.09M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $441.32M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $350.79M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $374.66M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $204.29M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $226.26M 10-K · filed 2018-03-08 | $226.26M 10-K · filed 2017-03-10 |
| 2016-09-30 | $174.42M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $176.00M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $112.07M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $127.14M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $137.25M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $131.79M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $141.02M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $153.35M 10-K · filed 2016-03-11 | $153.38M 10-K · filed 2015-03-24 |
| 2014-09-30 | $68.13M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $73.21M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $79.90M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $18.78M 10-K · filed 2015-03-24 |